Table 1.
Current BMI |
Maximum BMI |
||||||||||||
Family and Patient | Mutation Carriera | Sexb | Age (years) | Weight (kg) | Height (cm) | Absolute (kg/m2) | Percentile | Absolute (kg/m2)c,d | Percentilee | Waist/Hip Ratiof | Percent Body Fat (%)f | Leptin (ng/ml)f | Lifetime Positive Diet Historyc,g |
A | |||||||||||||
I:2 | +/− | F | 81 | 76 | 155 | 31.6 | 100 | NI | NC | NM | NM | 20.7 | NI |
II:1 | +/+ | M | 49 | 93 | 175 | 30.4 | 93 | NI | NC | .91 | 28.5 | 4.1 | NI |
II:2 | +/− | F | 45 | 103 | 163 | 38.8 | 99 | 40.7 | 100 | .90 | 45.5 | 58.1 | + |
II:3 | +/+ | M | 59 | 76 | 176 | 24.5 | 26 | 25 | 26 | .88 | 28.1 | 20.7 | − |
II:4 | +/+ | M | 46 | 70 | 175 | 22.9 | 17 | 23 | 17 | .81 | 27.4 | 2.8 | − |
II:5 | +/− | M | 50 | 97 | 171 | 33 | 97 | 33 | 97 | .99 | 33.9 | 29.9 | − |
II:6 | +/+ | F | 39 | 75 | 164 | 28.1 | 86 | 29 | 94 | .77 | 39.6 | 16.8 | + |
II:7 | +/+ | M | 42 | 72 | 180 | 22.2 | 16 | 22.5 | 59 | .81 | 21.4 | NM | + |
II:8 | +/+ | M | 39 | 79 | 177 | 25.2 | 53 | NR | NC | .90 | 26.3 | 5.3 | + |
II:9 | +/− | M | 40 | 94 | 178 | 29.7 | 92 | 29.7 | 92 | .97 | NM | 8.7 | − |
II:11 | +/+ | F | 61 | 63 | 167 | 22.6 | 18 | NR | NC | .93 | 35.5 | 14.9 | − |
III:1 | +/− | F | 22 | 117 | 171 | 40 | 100 | 42.8 | 100 | .89 | 46.6 | 63.1 | + |
III:2 | +/+ | M | 17 | 72 | 185 | 21 | 37 | NR | NC | .80 | 17.6 | 1.1 | − |
III:3 | +/− | F | 14 | 79 | 165 | 29 | 99 | 29 | 99 | .86 | 37.4 | 40.9 | − |
III:4 | +/+ | M | 12 | 81 | 162 | 30.9 | 100 | 31 | 100 | 1.02 | 35.8 | 94.1 | − |
III:5 | +/− | F | 21 | 78 | 168 | 27.7 | 98 | 28 | 98 | .75 | 39.7 | 65.8 | + |
III:7 | +/− | M | 20 | 110 | 194 | 29.2 | 98 | NI | NC | NM | NM | 24.9 | NI |
III:8 | +/+ | M | 18 | 66 | 178 | 21 | 37 | 21 | 37 | .79 | NM | 1.6 | − |
B | |||||||||||||
II:1 | +/+ | M | 68 | 88 | 173 | 29.4 | 86 | 38.4 | 100 | 1.07 | 30.9 | 1.9 | − |
II:2 | +/− | F | 64 | 106 | 153 | 45.3 | 100 | 45 | 100 | .77 | 58.3 | 91.9 | − |
II:3 | +/− | M | 60 | 82 | 171 | 27.9 | 67 | 32.2 | 96 | .79 | 31.3 | 39.9 | + |
II:4 | +/+ | F | 58 | 87 | 168 | 30.6 | 93 | 31 | 93 | NM | 43.1 | NM | − |
III:2 | +/− | F | 39 | 115 | 167 | 41.2 | 100 | 41.2 | 100 | .88 | 52.6 | 47.3 | + |
III:3 | +/− | M | 41 | 98 | 176 | 31.6 | 93 | NI | NC | .94 | 40.3 | 86.2 | NI |
III:5 | +/+ | F | 32 | 90 | 168 | 31.9 | 96 | NI | NC | NM | 33.5 | 41.6 | NI |
III:6 | +/− | M | 40 | 110 | 181 | 33.6 | 99 | 34 | 99 | .88 | 33.4 | 15 | − |
IV:1 | +/− | F | 19 | 139 | 165 | 51.1 | 100 | 40.4 | 100 | .82 | 55.3 | NM | + |
IV:3 | +/− | M | 8 | 53 | 143 | 25.9 | 97 | 26 | 97 | .96 | 40.1 | 88.9 | + |
C | |||||||||||||
I:1 | +/+ | M | 59 | 97 | 173 | 32.4 | 96 | 45.1 | 100 | .88 | 33.3 | 2.2 | − |
I:2 | +/− | F | 63 | 154 | 165 | 56.6 | 100 | 56.6 | 100 | .82 | 54.1 | 128 | + |
II:2 | +/− | F | 35 | 144 | 171 | 49.2 | 100 | 49 | 100 | .81 | 51.6 | 123 | + |
III:1 | +/− | F | 14 | 114 | 168 | 40.4 | 100 | 40 | 100 | .85 | 46.5 | 56.5 | + |
III:2 | +/+ | F | 12 | 59 | 154 | 24.9 | 97 | 25 | 97 | .84 | 34.5 | 16.8 | − |
III:3 | +/− | M | 10 | 58 | 140 | 29.8 | 100 | 30 | 100 | NM | NM | 45.9 | − |
Note.—Carriers were identified by means of four index patients, who belonged to three different families (A–C) (see fig. 1).
Genotype +/− indicates a haploinsufficiency carrier; +/+ indicates a wild type carrier.
F = female, M = male.
NI = Not interviewed.
NR = Not recalled.
NC = Not calculated.
NM = Not measured.
Plus sign (+) = positive finding; minus sign (−) = negative finding.